Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician September 15, 2001	Guideline for the Management of Heart Failure Caused by Systolic Dysfunction: Part II. Treatment Treatment recommendations for patients with left ventricular systolic dysfunction...
American Family Physician October 1, 2002 Konzem et al.	Controlling Hypertension in Patients with Diabetes Hypertension and diabetes mellitus are common diseases in the United States. Patients with diabetes have a much higher rate of hypertension than would be expected in the general population. Regardless of the antihypertensive agent used, a reduction in blood pressure helps to prevent diabetic complications.
American Family Physician December 1, 2004 McConaghy & Smith	Outpatient Treatment of Systolic Heart Failure Optimal outpatient treatment of systolic heart failure has three goals that should be pursued simultaneously: (1) control of risk factors for the development and progression of heart failure, (2) treatment of heart failure, and (3) education of patients.
American Family Physician October 15, 2001 Katherine L. Margo	Spironolactone in Left-Sided Heart Failure: How Does It Fit In? The familiar diuretic spironolactone has taken on new life as a treatment for left-sided congestive heart failure. More research is necessary to determine the order and combinations of spironolactone and other medications in slowing the progression of this disease...
American Family Physician February 1, 2005 Dickerson & Gibson	Management of Hypertension in Older Persons Antihypertensive therapy has been shown to reduce morbidity and mortality in older patients with elevated systolic or diastolic blood pressures.
American Family Physician April 15, 2001 Robert E. Hoyt & Lester Shawn	Reducing Readmissions for Congestive Heart Failure Hospital admission for congestive heart failure is extremely common and quite expensive, although it is frequently preventable...
American Family Physician September 1, 2003 Magill et al.	New Developments in the Management of Hypertension Advances in the management of hypertension have refined our understanding of systolic blood pressure, nutrition, medication selection, and hypertension in special populations.
American Family Physician July 15, 2000 Showkat A. Haji	Update on Digoxin Therapy in Congestive Heart Failure Congestive heart failure is a progressive disease with significant morbidity and mortality. Despite advances in the prevention and treatment of cardiovascular diseases, the incidence and prevalence of congestive heart failure have increased in recent years...
American Family Physician July 1, 2005 Micah L. Thorp	Diabetic Nephropathy: Common Questions Diabetic nephropathy, or diabetic kidney disease, affects 20% - 30% of patients with diabetes. This article addresses some of the common questions raised by physicians managing patients with this disease.
American Family Physician August 1, 2002 Mark W. Niedfeldt	Managing Hypertension in Athletes and Physically Active Patients Athletes and other physically active patients should be screened for hypertension and given appropriate therapy if needed.
American Family Physician December 15, 2003 Ezekowitz et al.	Stroke: Strategies for Primary Prevention Stroke is a leading cause of morbidity and mortality. Every year, approximately 500,000 Americans have a first stroke, and approximately 20 percent die within 30 days. This article summarizes strategies that have been shown to be effective in stroke prevention.
American Family Physician December 1, 2000 William E. Chavey	The Importance of Beta Blockers in the Treatment of Heart Failure Traditionally, beta blockers have been considered to be contraindicated in patients with heart failure. Recently, however, several large randomized, controlled mortality trials have been stopped early because of the effects of beta blockers...
American Family Physician October 15, 2003 Gavin et al.	Reducing Cardiovascular Disease Risk in Patients with Type 2 Diabetes By increasing patient awareness of the link between diabetes and heart disease, family physicians can encourage patients to take medications (including aspirin), stop smoking, lower blood pressure, and lower cholesterol and blood glucose levels.
American Family Physician August 15, 2005 Ward & Hume	STEPS - New Drug Reviews Olmesartan (Benicar) for Hypertension
American Family Physician October 15, 2000 Patricia A. Howard & Edward F. Ellerbeck	Optimizing Beta-Blocker Use After Myocardial Infarction Although beta-adrenergic blockers can significantly reduce mortality after a myocardial infarction, these agents are prescribed to only a minority of patients...
American Family Physician November 1, 2003 Scow et al.	Combination Therapy with ACE Inhibitors and Angiotensin-Receptor Blockers in Heart Failure This article reviews the literature and available evidence on the use of ACE inhibitors and angiotensin-receptor blockers in combination for the treatment of patients with congestive heart failure.
American Family Physician November 15, 2004 Snively & Gutierrez	Chronic Kidney Disease: Prevention and Treatment of Common Complications Family physicians have the opportunity to screen at-risk patients, identify affected patients, and ameliorate the impact of chronic kidney disease by initiating early therapy and monitoring disease progression.
American Family Physician March 15, 2006 Wilson & Sanford	Amlodipine/Atorvastatin (Caduet) for Preventing Heart Disease Amlodipine/atorvastatin offers no added benefit in safety, tolerability, or effectiveness over amlodipine and atorvastatin taken separately. It has not been shown to improve mortality or morbidity in patients who have hypertension with or without dyslipidemia.
American Family Physician November 15, 2000 Tarik M. Ramahi	Beta Blocker Therapy for Chronic Heart Failure Recent studies have shown that beta blocker therapy improves survival and reduces hospitalizations in patients who have chronic heart failure and left ventricular systolic dysfunction...
American Family Physician March 1, 2006 Satpathy et al.	Diagnosis and Management of Diastolic Dysfunction and Heart Failure With early diagnosis and proper management the prognosis of diastolic dysfunction is more favorable than that of systolic dysfunction. Distinguishing diastolic from systolic heart failure is essential because the optimal therapy for one may aggravate the other.
American Family Physician June 15, 2005 Hanna & Wenger	Secondary Prevention of Coronary Heart Disease in Elderly Patients A review of the scientific evidence for the secondary prevention of coronary heart disease in the elderly.
Nurse Practitioner February 2011 Jennifer M. Belavic	Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available.
Nurse Practitioner February 2012 Wood & Gordon	Preventing CVD in women: The NP's role This article focuses on the new American Heart Association guidelines for preventing cardiovascular disease in women and the nurse practitioner's role in implementing them.
American Family Physician November 15, 2002 Cynthia M. Williams	Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population.
American Family Physician April 1, 2004 Nina Solenski	Transient Ischemic Attacks: Part II. Treatment Risk factors for stroke should be evaluated in patients who have had a transient ischemic attack.
American Family Physician August 15, 2006 Morris, Hatcher & Reddy	Digoxin Therapy for Heart Failure: An Update Digoxin therapy has long been used to treat heart failure; however, its effectiveness was not completely known until recently. Results of the Digitalis Investigation Group trial showed that adding digoxin to standard heart failure therapy had no effect on mortality.
American Family Physician December 1, 2000 Assad Movahed	Beta Blockers and Congestive Heart Failure Heart failure is a complex condition, and its treatment requires consideration of two separate goals: symptom relief and tertiary prevention...
American Family Physician November 15, 2004 Charles T. Taylor	Eplerenone (Inspra) for Hypertension Eplerenone, a potassium-sparing diuretic similar to spironolactone, selectively blocks aldosterone to lower blood pressure. However, its safety profile is improved over spironolactone because of reduced progesterone and androgen-receptor effects.
American Family Physician January 15, 2006 Hollander-Rodriguez & Calvert	Hyperkalemia Hyperkalemia is a potentially life-threatening metabolic problem caused by inability of the kidneys to excrete potassium, impairment of the mechanisms that move potassium from the circulation into the cells, or a combination of these factors.
Nursing February 2010 Daniel A. Hussar	New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs.
Nursing May 2010 Debra Castner	Understanding the stages of chronic kidney disease This article will help you to recognize CKD and understand its stages so you can help your patient to modify risk factors, prevent further kidney damage, and manage complications. First, consider the scope of the problem.
American Family Physician January 15, 2002 Lori J. Mosca	Optimal Management of Cholesterol Levels and the Prevention of Coronary Heart Disease in Women Elevated levels of low-density lipoprotein cholesterol and triglycerides and low levels of high-density lipoprotein cholesterol are significant risk factors for coronary heart disease. Abundant data show inadequate utilization of lipid-lowering therapy in women...
Nursing June 2010 Daniel A. Hussar	New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs.
American Journal of Nursing May 2009 Kristen J. Overbaugh	Acute Coronary Syndrome Coronary artery disease, in which atherosclerotic plaque builds up inside the coronary arteries and restricts the flow of blood (and therefore the delivery of oxygen) to the heart, continues to be the number-one killer of Americans.
American Family Physician November 1, 2005 Eddie Needham	Management of Acute Renal Failure Acute renal failure is an acute loss of kidney function that occurs over days to weeks and results in an inability to appropriately excrete nitrogenous wastes and creatinine. In spite of this rapid decline in kidney function, patients with acute renal failure often have few symptoms.
American Family Physician May 1, 2006 Luma & Spiotta	Hypertension in Children and Adolescents The prevalence and rate of diagnosis of hypertension in children and adolescents appear to be increasing. Most childhood hypertension, particularly in preadolescents, is secondary to an underlying disorder.
American Family Physician January 15, 2001 Michael A. Crouch	Effective Use of Statins to Prevent Coronary Heart Disease Primary and secondary prevention trials have shown that use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (also known as statins) to lower an elevated low-density lipoprotein level can substantially reduce coronary events and death from coronary heart disease...
Nursing March 2011 Ali & Gray-Vickrey	Limiting the Damage From Acute Kidney Injury This article will discuss your role in early detection and management of AKI with an emphasis on care for older adults.
American Family Physician October 15, 2006 Sharonne N. Hayes	Preventing Cardiovascular Disease in Women The American Heart Association guidelines for cardiovascular disease prevention in women provide physicians with a clear plan for assessment and treatment of cardiovascular disease risk and personalization of treatment recommendations.
American Family Physician January 1, 2006 MODI Lowder	Medications for Migraine Prophylaxis Sufficient evidence and consensus exist to recommend propranolol, timolol, amitriptyline, divalproex, sodium valproate, and topiramate as first-line agents for migraine prevention.
American Family Physician March 1, 2007 Flood & Fleisher	Preparation of the Cardiac Patient for Noncardiac Surgery Perioperative myocardial infarction (MI) is a major cause of morbidity and mortality in patients who have noncardiac surgery.
Nursing June 2012 Streets & Vickers	Is this patient with heart failure a candidate for ultrafiltration? Similar to dialysis, ultrafiltration is a type of renal replacement therapy that may be indicated for patients with heart failure who have significant volume overload despite outpatient diuretic therapy.
American Family Physician December 15, 2000 Alan J. Garber	Attenuating Cardiovascular Risk Factors in Patients with Type 2 Diabetes All cardiovascular risk factors except smoking are more prevalent in patients with type 2 diabetes. In addition to exercise, weight control, aspirin therapy and blood pressure control, therapy to modify lipid profiles is usually necessary...
American Family Physician November 1, 2005 Snyder & Pendergraph	Detection and Evaluation of Chronic Kidney Disease Early treatment of chronic kidney disease and its complications may delay or prevent the development of end-stage renal disease. Consequently, detection of chronic kidney disease should be a priority for family physicians.
American Family Physician May 1, 2001 Beatriz Luna & Mark N. Feinglos	Oral Agents in the Management of Type 2 Diabetes Mellitus Currently, there are five distinct classes of hypoglycemic agents available, each class displaying unique pharmacologic properties...
American Family Physician April 1, 2001 Joan Bedinghaus	Coronary Artery Disease Prevention: What's Different for Women? Cardiovascular disease is the leading cause of death in women, as well as an important cause of disability, although many women and their physicians underestimate the risk...
Managed Care July 2004 Thomas Morrow	Nesiritide Speeds Recovery Time For Heart Failure Patients As clinicians recognize heart failure's neurohormonal component, a biologic agent may prove better than the small molecules.
American Family Physician July 15, 2001	NHBPEP Report on High Blood Pressure in Pregnancy: A Summary for Family Physicians
Nursing March 2012 Daniel A. Hussar	New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs.
American Family Physician September 15, 2005 Bonakdar & Guarneri	Coenzyme Q10 This is a safe but expensive supplement with preliminary benefit in neurology, including Parkinson's disease, and inconsistent results in cardiovascular disease requiring further long-term research.